CVKD — CADRENAL THERAPEUTICS INC
As of Q2 2026, 4 SEC-registered investment managers reported holding CVKD (CADRENAL THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $69.94K across 20.94K shares. That is -23.4% by share count (-6.38K shares) versus the previous quarter, while reported value moved -50.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 added to existing stakes, 1 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CVKD is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 53.91K | $365.52K | 0.00% | Reduce |
| Citadel Advisors history | Q3 2025 | 19.86K | $273.63K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 19.02K | $63.54K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q4 2025 | 7.50K | $50.85K | 0.00% | Hold |
| BlackRock Inc history | Q1 2026 | 5.50K | $28.14K | 0.00% | Add |
| Renaissance Technologies history | Q2 2024 | 59.49K | $27.96K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 1.11K | $3.71K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 706 | $2.36K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 99 | $331 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 1 | $7 | 0.00% | Hold |
| Citigroup Inc history | Q1 2026 | 1 | $5 | 0.00% | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- BlackRock Inc sold 5.50K sh · $28.14K
- Citigroup Inc sold 1 sh · $5
Fund Position History — shares by quarter (top 11 funds)
| Fund | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | — | — | 38.74K | 38.74K | 42.87K | 61.55K | — | 10.55K | 12.09K | 12.71K | 12.71K | 14.53K | 21.63K | 19.02K |
| UBS Group AG | 230 | 4 | 135 | — | — | — | — | 2.17K | 8.45K | 326 | 35 | 1.04K | 3 | 1.11K |
| Morgan Stanley | — | — | — | — | — | — | — | 1.15K | 1.13K | 430 | 880 | 1.08K | 100 | 706 |
| Wells Fargo & Co | 10 | 10 | 50 | 53 | 54 | — | — | — | 100 | 100 | 99 | 99 | 99 | 99 |
| Citadel Advisors | — | — | 29.11K | — | 55.85K | 54.54K | — | — | — | — | 19.86K | — | — | — |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | 3.28K | 3.38K | 3.52K | 5.50K | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | 100 | — | 7.50K | 7.50K | — | — |
| Bank of America Corp | — | — | — | — | — | 81 | 5 | 10 | 11 | 14 | 1 | 1 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | 1 | — |
| Vanguard Group | — | — | — | — | — | — | — | — | 45.63K | 48.59K | 54.24K | 53.91K | — | — |
| Renaissance Technologies | — | — | — | 79.10K | 148.14K | 59.49K | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details